These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35227544)
1. Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care? Chapman ER; Correa RJM; Palma DA; Van As N Clin Oncol (R Coll Radiol); 2022 May; 34(5):318-324. PubMed ID: 35227544 [No Abstract] [Full Text] [Related]
6. Adrenal oligometastasis cured with stereotactic ablative radiotherapy. Malone J; Pantarotto JR; Tiberi D; Malone S Radiol Case Rep; 2020 Nov; 15(11):2266-2270. PubMed ID: 32983297 [TBL] [Abstract][Full Text] [Related]
7. The Management of Oligometastases in Non-small Cell Lung Cancer - is Stereotactic Ablative Radiotherapy now Standard of Care? Ratnakumaran R; McDonald F Clin Oncol (R Coll Radiol); 2022 Nov; 34(11):753-760. PubMed ID: 36117126 [TBL] [Abstract][Full Text] [Related]
9. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases. Saluja R; Cheung P; Zukotynski K; Emmenegger U Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer. Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742 [TBL] [Abstract][Full Text] [Related]
11. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637 [TBL] [Abstract][Full Text] [Related]
13. Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy. Dohopolski M; Iyengar P Ann Palliat Med; 2021 May; 10(5):5944-5953. PubMed ID: 33691460 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial. Palma DA; Olson R; Harrow S; Correa RJM; Schneiders F; Haasbeek CJA; Rodrigues GB; Lock M; Yaremko BP; Bauman GS; Ahmad B; Schellenberg D; Liu M; Gaede S; Laba J; Mulroy L; Senthi S; Louie AV; Swaminath A; Chalmers A; Warner A; Slotman BJ; de Gruijl TD; Allan A; Senan S BMC Cancer; 2019 Aug; 19(1):816. PubMed ID: 31426760 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient. Weber B; Liu M; Sobkin P; Morris SW; Hout D; van der Westhuizen N; Tonseth RP; Saltman DL J Med Radiat Sci; 2016 Mar; 63(1):67-70. PubMed ID: 27087977 [TBL] [Abstract][Full Text] [Related]
16. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Ashworth A; Rodrigues G; Boldt G; Palma D Lung Cancer; 2013 Nov; 82(2):197-203. PubMed ID: 24051084 [TBL] [Abstract][Full Text] [Related]
17. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study. Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer. Abbas G; Danish A; Krasna MJ Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature. Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035 [TBL] [Abstract][Full Text] [Related]
20. Mature Experiences Using Local Therapy for Oligometastases. Tchelebi LT; Goodman KA Semin Radiat Oncol; 2021 Jul; 31(3):180-185. PubMed ID: 34090644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]